BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34680065)

  • 1. Circulating MicroRNAs as Novel Potential Diagnostic Biomarkers for Osteosarcoma: A Systematic Review.
    Gally TB; Aleluia MM; Borges GF; Kaneto CM
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
    Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
    Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
    Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
    Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis.
    Zhang WT; Zhang GX; Gao SS
    Technol Cancer Res Treat; 2021; 20():15330338211011958. PubMed ID: 33902358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
    Ouyang L; Liu P; Yang S; Ye S; Xu W; Liu X
    Med Oncol; 2013 Mar; 30(1):340. PubMed ID: 23269581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F; Cui Y; Zhou C; Gao K; Wu L
    PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
    Lamichhane SR; Thachil T; Gee H; Milic N
    Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
    Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients.
    Shi L; Xie C; Zhu J; Chen X
    Ann Diagn Pathol; 2020 Jun; 46():151488. PubMed ID: 32172218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Plasma MicroRNA Signature in Osteosarcoma Patients.
    Allen-Rhoades W; Yustein JT
    Methods Mol Biol; 2018; 1699():113-118. PubMed ID: 29086373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Liquid Biopsy in the Treatment of Patient with OS.
    Shulman DS; Crompton BD
    Adv Exp Med Biol; 2020; 1257():95-105. PubMed ID: 32483734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in osteosarcoma.
    Zhang J; Yan YG; Wang C; Zhang SJ; Yu XH; Wang WJ
    Clin Chim Acta; 2015 Apr; 444():9-17. PubMed ID: 25661090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNAs as circulating biomarkers in osteosarcoma patients.
    Botti G; Giordano A; Feroce F; De Chiara AR; Cantile M
    J Cell Physiol; 2019 Nov; 234(11):19249-19255. PubMed ID: 31032924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
    Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
    J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples.
    Liu HP; Lai HM; Guo Z
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32607548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.